SIX
The Swiss Stock Exchange is Europe’s 4th biggest stock exchange by market-cap as well as by trading volume. Featuring 3 of Europe’s top 5 most capitalized companies, the exchange is one of Europe’s leading listing venues for the Biotech (Life Sciences, Pharmaceuticals, Medical Technology), FMCG, Financial Services and Heavy Industry sectors.
In the Trading space, SIX is characterized by its ability to provide Europe’s highest market share in Swiss blue chips. As a consequence, the Swiss Stock Exchange offers its clients exceptional liquidity. In addition, the exchange features over 1’500 Exchange Traded Funds (ETFs) making it one of the biggest in Europe.
For Post-Trade services, the exchange offers comprehensive end-to-end services: Clearing, through to Swiss & Global Custody and Collateral Management.
SIX at a glance:
| Segments and Admission Criteria |
|
| Specialization/Outstanding Services | To reflect the high importance of the life sciences sector, two special indices – the SXI Life Sciences® and its more narrowly circumscribed sub-index Swiss Bio+Medtech Index (SXI) – were created in 2004. |
| Market Segmentation | A main market with uniform listing requirements for all listed companies |
| Market Cap |
|
| Listed Companies |
|
| Membership in networks/associations |
|
| Date of Incorporation/Number of Employees | SIX: 2008, Employees as of 30 June 2020: 3’407 FTE. Oldest predecessor company of SIX ist Ticker AG: Foundation year: 1930 |
Contact:
| Address | Pfingstweidstrasse 110 8021 Zurich Switzerland |
| Telephone/Telefax | +41 58 399 21 11 |
| Contact form | www.six-group.com/de/company/contacts/head-office.html |
| Web Address | www.six-group.com |
| Social Media | LinkedIn Twitter Facebook Instagram Youtube |
- Schweizer Kapitalmarkt in Krisenzeiten gefestigt
- Nächstes IPO abgesagt: Chronext verschiebt Börsengang
- Schweizer Leitindex legt zu – Nachholbedarf bei IPOs
- Neues Segment für KMU: Sparks startet an der Schweizer Börse SIX
- Montana Aerospace AG legt Preisspanne für IPO fest
- Achiko Limited: Next Level Share-Gaming in der Schweiz
- Rückkehr an die Schweizer Börse? SIG steht offenbar vor IPO-Comeback
- Hauck & Aufhäuser startet Coverage von Börsenneuling ASMALLWORLD: 'Buy'
- Polyphor will an Schweizer Börse debütieren
- „Vorteil für Mitglieder ganz schnell erreicht“
- Medartis plant Börsengang in der Schweiz
- Milliarden-IPO in der Schweiz: Landis+Gyr debütiert an der Börse
- Landis+Gyr will noch im Juli an die Schweizer Börse
- DocMorris-Mutter Zur Rose legt Börsendebüt hin
- Landis+Gyr: Bald Mega-IPO in der Schweiz?
- Zur Rose legt Preisspanne für geplanten Börsengang fest
- Zur Rose: Börsengang in Sichtweite
- Europas größtes IPO bislang: Galenica Santé debütiert an Schweizer Börse
- Galenica Santé plant Börsengang an der SIX
- Dritter Börsenneuling in der Schweiz? Investis hat IPO-Pläne